These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32588254)

  • 1. Evaluation of the usefulness of EQ-5D as a patient-reported outcome measure using the Paretian classification of health change among patients with chronic heart failure.
    Jonsson Å; Orwelius L; Dahlstrom U; Kristenson M
    J Patient Rep Outcomes; 2020 Jun; 4(1):50. PubMed ID: 32588254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of patients' health-related quality of life using EQ-5D-3L in 11 Swedish National Quality Registers.
    Teni FS; Rolfson O; Devlin N; Parkin D; Nauclér E; Burström K;
    BMJ Open; 2022 Jan; 12(1):e048176. PubMed ID: 34992101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancies between self- and proxy-rated quality of life in people living with dementia.
    Buchholz M; Engel L; Kleinke F; Mühlichen F; Pfaff M; Platen M; Rädke A; Scharf A; Weber N; van den Berg N; Hoffmann W; Michalowsky B
    Alzheimers Dement (N Y); 2024; 10(2):e12486. PubMed ID: 38899046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Hakimi Z; Herdman M; Pavesi M; Devlin N; Nazir J; Hoyle C; Odeyemi IA
    Qual Life Res; 2017 May; 26(5):1187-1195. PubMed ID: 27896711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the diversity and determinants of health-related quality of life measures in patients with acute heart failure.
    Patil D; Tang HJ; Kuo FH; Toh HS; Yang IN; Chang WT; Lee MC; Chung KN; Huang CY; Hsu WH; Chang TC; Shih JY; Liao CT
    ESC Heart Fail; 2024 Mar; ():. PubMed ID: 38509031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials.
    Simpson EL
    Dermatol Ther (Heidelb); 2017 Jun; 7(2):243-248. PubMed ID: 28503712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life assessment in patients with heart failure: validity of the German version of the generic EQ-5D-5L™.
    Boczor S; Daubmann A; Eisele M; Blozik E; Scherer M
    BMC Public Health; 2019 Nov; 19(1):1464. PubMed ID: 31694584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study.
    Filippatos G; Maggioni AP; Lam CSP; Pieske-Kraigher E; Butler J; Spertus J; Ponikowski P; Shah SJ; Solomon SD; Scalise AV; Mueller K; Roessig L; Bamber L; Gheorghiade M; Pieske B
    Eur J Heart Fail; 2017 Jun; 19(6):782-791. PubMed ID: 28586537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data.
    Devlin NJ; Parkin D; Browne J
    Health Econ; 2010 Aug; 19(8):886-905. PubMed ID: 20623685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the effects on HR-QoL of treatment for overactive bladder: a detailed analysis of EQ-5D clinical trial data for mirabegron.
    Pavesi M; Devlin N; Hakimi Z; Nazir J; Herdman M; Hoyle C; Odeyemi IA
    J Med Econ; 2013 Jul; 16(7):866-76. PubMed ID: 23647446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collection and use of EQ-5D for follow-up, decision-making, and quality improvement in health care - the case of the Swedish National Quality Registries.
    Ernstsson O; Janssen MF; Heintz E
    J Patient Rep Outcomes; 2020 Sep; 4(1):78. PubMed ID: 32936347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the EQ-5D measure quality of life in schizophrenia?
    Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
    J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study.
    Scott D; Ferguson GD; Jelsma J
    Health Qual Life Outcomes; 2017 Jan; 15(1):12. PubMed ID: 28103872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.
    Greene ME; Rader KA; Garellick G; Malchau H; Freiberg AA; Rolfson O
    Clin Orthop Relat Res; 2015 Nov; 473(11):3383-90. PubMed ID: 25488404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
    Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
    Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.
    Vedin O; Lam CSP; Koh AS; Benson L; Teng THK; Tay WT; Braun OÖ; Savarese G; Dahlström U; Lund LH
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28615366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.